Bausch + Lomb Remains Public After Exploring Potential Sale
Contact lens manufacturer Bausch + Lomb has announced it will remain a publicly traded company.
In December, the company initiated discussions regarding a potential sale or other options to facilitate its separation from its parent company, Bausch Health.
One of the explored options was a private sale to a third-party buyer. However, after engaging with potential buyers, Bausch + Lomb has decided against pursuing this option at this time.
The company will continue to seek alternatives for a full separation from Bausch Health.